{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:41:45Z","timestamp":1791207705335,"version":"4.1.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T00:00:00Z","timestamp":1478476800000},"content-version":"vor","delay-in-days":2159,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1093\/nar\/gkq1277","type":"journal-article","created":{"date-parts":[[2010,12,11]],"date-time":"2010-12-11T20:25:34Z","timestamp":1292099134000},"page":"3350-3362","source":"Crossref","is-referenced-by-count":144,"title":["Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides"],"prefix":"10.1093","volume":"39","author":[{"given":"C\u00e9lia","family":"Floquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Deforges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Bidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,12,10]]},"reference":[{"key":"key\n\t\t\t\t20170510154831_B1","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1093\/nar\/13.17.6265","article-title":"Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin","volume":"13","author":"Burke","year":"1985","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170510154831_B2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI7866","article-title":"Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice","volume":"104","author":"Barton-Davis","year":"1999","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170510154831_B3","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/nm1197-1280","article-title":"Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line","volume":"3","author":"Bedwell","year":"1997","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170510154831_B4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tig.2008.08.010","article-title":"Introducing sense into nonsense in treatments of human genetic diseases","volume":"24","author":"Linde","year":"2008","journal-title":"Trends Genet."},{"key":"key\n\t\t\t\t20170510154831_B5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.clpt.6100012","article-title":"Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy","volume":"81","author":"Zingman","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"key\n\t\t\t\t20170510154831_B6","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJMoa022170","article-title":"Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations","volume":"349","author":"Wilschanski","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170510154831_B7","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1164\/ajrccm.163.7.2004001","article-title":"Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis","volume":"163","author":"Clancy","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"key\n\t\t\t\t20170510154831_B8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.1023","article-title":"Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations","volume":"49","author":"Wagner","year":"2001","journal-title":"Ann. Neurol."},{"key":"key\n\t\t\t\t20170510154831_B9","first-page":"15","article-title":"Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results","volume":"22","author":"Politano","year":"2003","journal-title":"Acta Myol."},{"key":"key\n\t\t\t\t20170510154831_B10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.22024","article-title":"Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy","volume":"67","author":"Malik","year":"2010","journal-title":"Ann. Neurol."},{"key":"key\n\t\t\t\t20170510154831_B11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1741-7015-5-5","article-title":"In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study","volume":"5","author":"Sermet-Gaudelus","year":"2007","journal-title":"BMC Med."},{"key":"key\n\t\t\t\t20170510154831_B12","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1101\/gad.12.19.2973","article-title":"The complexity of p53 modulation: emerging patterns from divergent signals","volume":"12","author":"Giaccia","year":"1998","journal-title":"Genes Dev."},{"key":"key\n\t\t\t\t20170510154831_B13","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1101\/gad.8.23.2817","article-title":"Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1\/cip1","volume":"8","author":"Wagner","year":"1994","journal-title":"Genes Dev."},{"key":"key\n\t\t\t\t20170510154831_B14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.7973635","article-title":"p53 status and the efficacy of cancer therapy in vivo","volume":"266","author":"Lowe","year":"1994","journal-title":"Science"},{"key":"key\n\t\t\t\t20170510154831_B15","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1038\/sj.onc.1206949","article-title":"The role of p53 in chemosensitivity and radiosensitivity","volume":"22","author":"El-Deiry","year":"2003","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170510154831_B16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","article-title":"p53-dependent apoptosis modulates the cytotoxicity of anticancer agents","volume":"74","author":"Lowe","year":"1993","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170510154831_B17","first-page":"2340","article-title":"Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions","volume":"52","author":"Takahashi","year":"1992","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170510154831_B18","first-page":"1791","article-title":"Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene","volume":"6","author":"Casey","year":"1991","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170510154831_B19","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1101\/gad.10.19.2438","article-title":"p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells","volume":"10","author":"Chen","year":"1996","journal-title":"Genes Dev."},{"key":"key\n\t\t\t\t20170510154831_B20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1517\/14712598.6.1.55","article-title":"Adenovirus p53 gene therapy","volume":"6","author":"Roth","year":"2006","journal-title":"Expert. Opin. Biol. Ther."},{"key":"key\n\t\t\t\t20170510154831_B21","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1089\/hum.2005.16.1016","article-title":"Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers","volume":"16","author":"Peng","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"key\n\t\t\t\t20170510154831_B22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.semcancer.2010.02.006","article-title":"Therapeutic targeting of p53 by small molecules","volume":"20","author":"Selivanova","year":"2010","journal-title":"Semin. Cancer Biol."},{"key":"key\n\t\t\t\t20170510154831_B23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/tlo.09250","article-title":"Targeting p53 for novel anticancer therapy","volume":"3","author":"Wang","year":"2010","journal-title":"Transl. Oncol."},{"key":"key\n\t\t\t\t20170510154831_B24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm0302-282","article-title":"Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound","volume":"8","author":"Bykov","year":"2002","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170510154831_B25","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1172\/JCI32481","article-title":"CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice","volume":"117","author":"Tang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170510154831_B26","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/jcb.21794","article-title":"PRIMA-1 synergizes with adriamycin to induce cell death in non-small cell lung cancer cells","volume":"104","author":"Magrini","year":"2008","journal-title":"J. Cell Biochem."},{"key":"key\n\t\t\t\t20170510154831_B27","first-page":"411","article-title":"PRIMA-1MET inhibits growth of mouse tumors carrying mutant p53","volume":"30","author":"Zache","year":"2008","journal-title":"Cell Oncol."},{"key":"key\n\t\t\t\t20170510154831_B28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.gt.3302211","article-title":"Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment","volume":"11","author":"Bidou","year":"2004","journal-title":"Gene Ther."},{"key":"key\n\t\t\t\t20170510154831_B29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0165-4608(99)00253-8","article-title":"Establishment and characterization of a new cell line derived from a human primary breast carcinoma","volume":"120","author":"Wang","year":"2000","journal-title":"Cancer Genet. Cytogenet."},{"key":"key\n\t\t\t\t20170510154831_B30","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1017\/S1355838200000443","article-title":"Nonsense-mediated decay mutants do not affect programmed -1 frameshifting","volume":"6","author":"Bidou","year":"2000","journal-title":"RNA"},{"key":"key\n\t\t\t\t20170510154831_B31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/ana.20052","article-title":"Readthrough of dystrophin stop codon mutations induced by aminoglycosides","volume":"55","author":"Howard","year":"2004","journal-title":"Ann. Neurol."},{"key":"key\n\t\t\t\t20170510154831_B32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jgm.1140","article-title":"Drug-induced readthrough of premature stop codons leads to the stabilization of laminin alpha2 chain mRNA in CMD myotubes","volume":"10","author":"Allamand","year":"2008","journal-title":"J. Gene Med."},{"key":"key\n\t\t\t\t20170510154831_B33","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ajh.21539","article-title":"Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients","volume":"84","author":"Salvatori","year":"2009","journal-title":"Am. J. Hematol."},{"key":"key\n\t\t\t\t20170510154831_B34","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1101\/gad.1339905","article-title":"p53 isoforms can regulate p53 transcriptional activity","volume":"19","author":"Bourdon","year":"2005","journal-title":"Genes Dev."},{"key":"key\n\t\t\t\t20170510154831_B35","first-page":"73","article-title":"Real-time polymerase chain reaction quantitation of relative expression of genes modulated by p53 using SYBR Green I","volume":"234","author":"Stagliano","year":"2003","journal-title":"Methods Mol. Biol."},{"key":"key\n\t\t\t\t20170510154831_B36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00063030-200923030-00003","article-title":"Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in development","volume":"23","author":"Rowe","year":"2009","journal-title":"BioDrugs"},{"key":"key\n\t\t\t\t20170510154831_B37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00109-001-0317-z","article-title":"Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system","volume":"80","author":"Keeling","year":"2002","journal-title":"J. Mol. Med."},{"key":"key\n\t\t\t\t20170510154831_B38","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/gut.2008.169805","article-title":"Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons","volume":"59","author":"Zilberberg","year":"2010","journal-title":"Gut"},{"key":"key\n\t\t\t\t20170510154831_B39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1531-8249(200008)48:2<164::AID-ANA5>3.0.CO;2-B","article-title":"Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy","volume":"48","author":"Howard","year":"2000","journal-title":"Ann. Neurol."},{"key":"key\n\t\t\t\t20170510154831_B40","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1017\/S1355838200000716","article-title":"Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system","volume":"6","author":"Manuvakhova","year":"2000","journal-title":"RNA"},{"key":"key\n\t\t\t\t20170510154831_B41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ejhg.2009.122","article-title":"In vitro readthrough of termination codons by gentamycin in the Stuve-Wiedemann Syndrome","volume":"18","author":"Bellais","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"key\n\t\t\t\t20170510154831_B42","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00018-009-0177-1","article-title":"Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors","volume":"67","author":"Nicholson","year":"2010","journal-title":"Cell Mol. Life Sci."},{"key":"key\n\t\t\t\t20170510154831_B43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molmed.2006.05.005","article-title":"Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges","volume":"12","author":"Kuzmiak","year":"2006","journal-title":"Trends Mol. Med."},{"key":"key\n\t\t\t\t20170510154831_B44","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/BST0360497","article-title":"Recognition of nonsense mRNA: towards a unified model","volume":"36","author":"Muhlemann","year":"2008","journal-title":"Biochem. Soc. Trans."},{"key":"key\n\t\t\t\t20170510154831_B45","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1073\/pnas.76.10.5134","article-title":"Interference of nonsense mutations with eukaryotic messenger RNA stability","volume":"76","author":"Losson","year":"1979","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170510154831_B46","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1261\/rna.5147804","article-title":"Leaky termination at premature stop codons antagonizes nonsense-mediated mRNA decay in S. cerevisiae","volume":"10","author":"Keeling","year":"2004","journal-title":"RNA"},{"key":"key\n\t\t\t\t20170510154831_B47","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/MCB.18.5.2932","article-title":"Selenium deficiency reduces the abundance of mRNA for Se-dependent glutathione peroxidase 1 by a UGA-dependent mechanism likely to be nonsense codon-mediated decay of cytoplasmic mRNA","volume":"18","author":"Moriarty","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170510154831_B48","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1017\/S1355838298971990","article-title":"Cis-acting elements are required for selenium regulation of glutathione peroxidase-1 mRNA levels","volume":"4","author":"Weiss","year":"1998","journal-title":"RNA"},{"key":"key\n\t\t\t\t20170510154831_B49","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","article-title":"Aminoglycosides: nephrotoxicity","volume":"43","author":"Mingeot-Leclercq","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"key\n\t\t\t\t20170510154831_B50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tox.2008.04.015","article-title":"Aminoglycoside induced ototoxicity","volume":"249","author":"Guthrie","year":"2008","journal-title":"Toxicology"},{"key":"key\n\t\t\t\t20170510154831_B51","doi-asserted-by":"crossref","first-page":"15394","DOI":"10.1073\/pnas.0610878104","article-title":"A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin","volume":"104","author":"Yang","year":"2007","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170510154831_B52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbagen.2004.12.006","article-title":"Apolipoprotein E3 (apoE3) safeguards pig proximal tubular LLC-PK1 cells against reduction in SGLT1 activity induced by gentamicin C","volume":"1722","author":"Takamoto","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20170510154831_B53","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1074\/jbc.M806728200","article-title":"Poly-L-aspartic acid enhances and prolongs gentamicin-mediated suppression of the CFTR-G542X mutation in a cystic fibrosis mouse model","volume":"284","author":"Du","year":"2009","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170510154831_B54","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.bmc.2010.03.060","article-title":"Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations","volume":"18","author":"Nudelman","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"key\n\t\t\t\t20170510154831_B55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170510154831_B56","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1073\/pnas.0711795105","article-title":"PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model","volume":"105","author":"Du","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170510154831_B57","first-page":"783","article-title":"Drug evaluation: PTC-124\u2013a potential treatment of cystic fibrosis and Duchenne muscular dystrophy","volume":"9","author":"Hamed","year":"2006","journal-title":"IDrugs"},{"key":"key\n\t\t\t\t20170510154831_B58","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.201001-0137OC","article-title":"Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis","volume":"182","author":"Sermet-Gaudelus","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/39\/8\/3350\/16783073\/gkq1277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T20:00:56Z","timestamp":1712001656000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article-lookup\/doi\/10.1093\/nar\/gkq1277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,10]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,12,10]]},"published-print":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkq1277","relation":{},"ISSN":["1362-4962","0305-1048"],"issn-type":[{"value":"1362-4962","type":"electronic"},{"value":"0305-1048","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,10]]}}}